Analysed KARYOPHARM THERAPEUTICS INC (KPTI:NASDAQ) News Sources
Endometrial Cancer Market Share Analysis and Industry Trends (2026-2031) Featuring Merck, Eisai, Karyopharm Therapeutics, Context Therapeutics, Seagen and More
07-08-2026
yahoo.com
Karyopharm Reports Second Quarter 2026 Financial Results and Highlights Continued Progress Toward Myelofibrosis sNDA Submission
13-08-2026
yahoo.com
Karyopharm Therapeutics Inc (KPTI) (Q2 2026) Earnings Call Highlights: SENTRY Trial Success and ...
13-08-2026
yahoo.com
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01-09-2026
yahoo.com
What is the current price of KARYOPHARM THERAPEUTICS INC (KPTI:NASDAQ)?
The current price of KARYOPHARM THERAPEUTICS INC (KPTI:NASDAQ) is $0.3901.
KARYOPHARM THERAPEUTICS INC (KPTI:NASDAQ) absolute price change since previous trading day?
The absolute price change of KARYOPHARM THERAPEUTICS INC (KPTI:NASDAQ) since the previous trading day is $0.0393.
KARYOPHARM THERAPEUTICS INC (KPTI:NASDAQ) percentage price change since previous trading day?
The percentage price change of KARYOPHARM THERAPEUTICS INC (KPTI:NASDAQ) since the previous trading day is 11.203%.
What is the most recent average sentiment score for KARYOPHARM THERAPEUTICS INC (KPTI:NASDAQ)?
The most recent average sentiment score for KARYOPHARM THERAPEUTICS INC (KPTI:NASDAQ) is 50 out of 100.
What is the most recent average sentiment for KARYOPHARM THERAPEUTICS INC (KPTI:NASDAQ)?
The most recent sentiment for KARYOPHARM THERAPEUTICS INC (KPTI:NASDAQ) is .
SEC-8K** Filing Available For KARYOPHARM THERAPEUTICS INC (KPTI:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.